Select Publications
Journal articles
2008, 'PYY transgenic mice are protected against diet-induced and genetic obesity', Neuropeptides, 42, pp. 19 - 30, http://dx.doi.org/10.1016/j.npep.2007.11.003
,2008, 'Reduced anxiety-like and depression-related behavior in neuropeptide YY4 receptor knockout mice', Genes Brain and Behavior, 7, pp. 532 - 542
,2008, 'Y1 receptors are critical for the proliferation of adult mouse precursor cells in the olfactory neuroepithelium', Journal of Neurochemistry, 105, pp. 641 - 652, http://dx.doi.org/10.1111/j.1471-4159.2007.05188.x
,2007, 'Y2, Y4 receptors and obesity', Expert Review of Endocrinology and Metabolism, 2, pp. 163 - 173, http://dx.doi.org/10.1586/17446651.2.2.163
,2007, 'Erratum: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome (Nature Medicine (2007) 13, (803-811))', Nature Medicine, 13, pp. 1120, http://dx.doi.org/10.1038/nm0907-1120
,2007, 'Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome', Nature Medicine, 13, pp. 803 - 811, http://dx.doi.org/10.1038/nm1611
,2007, 'Anticonvulsant and neuroprotective actions of endogenous dynorphin', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a10
,2007, 'Behavioral profiling of NPY in aggression and neuropsychiatric diseases', Peptides, 28, pp. 326 - 333
,2007, 'Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice', Molecular Endocrinology, 21, pp. 1722 - 1735
,2007, 'Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors', Brain, 130, pp. 1017 - 1028
,2007, 'Experiments to localize the site for the anxiogenic action of NPY mediated by Y2 receptors in the mouse brain', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a14
,2007, 'Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways', Endocrinology, 148, pp. 2056 - 2065
,2007, 'Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development', Federation of American Societies for Experimantal Biology Journal, 21, pp. 2108 - 2112
,2007, 'Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression', The Journal of Biological Chemistry, 282, pp. 19082 - 19091
,2007, 'Neuropeptide Y in the recurrent mossy fiber pathway', Peptides, 28, pp. 357 - 364
,2007, 'Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus', Neurobiology of Disease, 26, pp. 174 - 188
,2007, 'Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis', The Journal of Biological Chemistry, 282, pp. 19092 - 19102, http://dx.doi.org/10.1074/jbc.M700644200
,2007, 'NPY and receptors in immune and inflammatory diseases', Current Topics in Medicinal Chemistry, 7, pp. 1743 - 1752
,2007, 'The control of bone remodeling by neuropeptide Y receptors', Peptides, 28, pp. 320 - 325
,2007, 'The role of peptide YY in regulating glucose homeostasis', Peptides, 28, pp. 390 - 395
,2007, 'The Y-1 receptor for NPY: A key modulator of the adaptive immune system', Peptides, 28, pp. 453 - 458
,2007, 'Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1', Nature Medicine, 13, pp. 1333 - 1340
,2006, 'Erratum: Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice (Journal of Biological Chemistry (2006) 281, (23436-23444))', Journal of Biological Chemistry, 281, pp. 38966
,2006, 'The Central Control of Bone Remodeling', , pp. 361 - 376, http://dx.doi.org/10.1016/B978-012088562-6/50022-4
,2006, 'NPY and bone.', EXS, pp. 171 - 182, http://dx.doi.org/10.1007/3-7643-7417-9_13
,2006, 'Peptide YY: Lessons from mouse models', Current Opinion in Endocrinology and Diabetes, 13, pp. 65 - 69, http://dx.doi.org/10.1097/01.med.0000200524.26578.3b
,2006, 'Hypothalamic neuropeptide Y exerts a negative effect on cortical bone formation', Journal of Bone and Mineral Research, 21, pp. S65 - S65, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240866300247&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2006, 'Central control of cortical bone homeostasis: Neuropeptide Y exerts a negative effect on cortical bone formation', Bone, 38, pp. S6 - S6
,2006, 'Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals', Journal of Comparative Neurology, 499, pp. 357 - 390
,2006, 'Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity', Endocrinology, 147, pp. 5094 - 5101
,2006, 'Conditional deletion of hypothalamic Y2 receptors reverts gonadectomy-induced bone loss in adult mice', The Journal of Biological Chemistry, 281, pp. 23436 - 23444, http://dx.doi.org/10.1074/jbc.M604839200
,2006, 'Critical role for peptide YY in protein-mediated satiation and body-weight regulation', Cell Metabolism, 4, pp. 223 - 233
,2006, 'Deletion of hypothalamic neuropeptide Y2-receptors in adult mice protects against continued ovariectomy-induced bone loss', Bone, 38, pp. S6 - S6
,2006, 'Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: Evidence from receptor knockout mice', Epilepsia, 47, pp. 773 - 780
,2006, 'Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats', Neuropharmacology, 51, pp. 1129 - 1136
,2006, 'Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain', Neuropeptides, 40, pp. 115 - 123
,2006, 'Effect of Y-1 receptor deficiency on motor activity, exploration, and anxiety', Behavioural Brain Research, 167, pp. 87 - 93
,2006, 'Emotional behavior in aged neuropeptide Y (NPY)Y-2 knockout mice', Journal of Molecular Neuroscience, 28, pp. 239 - 245
,2006, 'Hypothalamic regulation of cortical bone mass: Opposing activity of Y2 receptor and leptin pathways', Journal of Bone and Mineral Research, 21, pp. 1600 - 1607
,2006, 'Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes', Neuropeptides, 40, pp. 317 - 324
,2006, 'Neuropeptide Y (NPY) Y-4 receptor selective agonists based on NPY(32-36): Development of an anorectic Y-4 receptor selective agonist with picomolar affinity', Journal of Medicinal Chemistry, 49, pp. 2661 - 2665
,2006, 'Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: correlation with Y2 receptor plasticity', Neuroscience, 143, pp. 1085 - 1094
,2006, 'Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity', Diabetologia, 49, pp. 1360 - 1370
,2006, 'Selective increase of dark phase water intake in neuropeptide-Y Y2 and Y4 receptor knockout mice', Behavioural Brain Research, 168, pp. 255 - 260
,2006, 'The role of neuropeptide Y in the neuroproliferation of adult olfactory stem cells', CYTOMETRY PART A, 69A, pp. 407 - 408
,2006, 'Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice', Diabetes, 55, pp. 19 - 26
,2005, 'Erratum: c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action (Journal of Clinical Investigation (2004) 114 (1326-1333) (doi:10.1172/JCI200421480))', Journal of Clinical Investigation, 115, pp. 476, http://dx.doi.org/10.1172/JCI200521480C1
,2005, 'Y2 receptors and the central regulation of cortical bone: Reciprocal activity to leptin', Bone, 36, pp. S142 - S142, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000229979900086&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2005, 'Central regulation of cortical bone: Opposing effects of Y2 receptor and leptin pathways', Journal of Bone and Mineral Research, 20, pp. S413 - S414, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233503805186&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
,2005, 'A fundamental bimodal role for neuropeptide Y1 receptor in the immune system', Journal of Experimental Medicine, 202, pp. 1527 - 1538
,